Effect of L-asparaginase therapy upon some indices of protein metabolism in leukemic patients.
D000208:Acute Disease; D000328:Adult; D000596:Amino Acids / Q000097:blood / Q000652:urine; D001215:Asparaginase / Q000494:pharmacology / Q000627:therapeutic use*; D001798:Blood Proteins / Q000378:metabolism*; D002570:Ceruloplasmin / Q000097:blood; D002784:Cholesterol / Q000097:blood; D002802:Cholinesterases / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004789:Enzyme Activation / Q000187:drug effects; D005176:Factor XIII / Q000378:metabolism; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D007938:Leukemia / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008297:Male; D010958:Plasminogen / Q000378:metabolism; D014750:Vincristine / Q000627:therapeutic use
D000596:Amino Acids; D001798:Blood Proteins; D008055:Lipids; D008074:Lipoproteins; D014750:Vincristine; D003520:Cyclophosphamide; D005340:Fibrinogen; D010958:Plasminogen; D005176:Factor XIII; D002784:Cholesterol; D002570:Ceruloplasmin; D002802:Cholinesterases; D001215:Asparaginase; D003630:Daunorubicin